{
    "info": {
        "nct_id": "NCT06831084",
        "official_title": "Acute Radiation Dermatitis After Adjuvant Radiotherapy for Breast Cancer Patients with the Use of Silver-Plated Technology: a Single Arm Phase II Trial",
        "inclusion_criteria": "1. ECOG ≤ 2\n2. Male or female patients with breast cancer or breast carcinoma in situ who are recommended to receive adjuvant radiotherapy to the breast +/- regional lymph nodes or are planned to receive adjuvant radiotherapy to the chest wall and regional lymph nodes over 3 to 4 weeks.\n3. Patients who will receive all of their RT at Magee Women's Hospital.\n4. Agreeable to use of SPT dressing as directed (changing once weekly during RT and the additional 2 weeks following completion of RT).\n5. Agreeable that any normal or physician recommended skin care regimen is to be used 1 hour prior to use of SPT dressing.\n6. Agreeable to completion of assessments and skin checks and in person follow up at about 1 month following completion of RT.\n7. Must have the ability to understand and the willingness to sign a written informed consent document.\nHealthy volunteers allowed\nMust have minimum age of 18 Years",
        "exclusion_criteria": "1. Prior RT to the breast +/- regional lymph nodes or prior RT to the chest wall and regional lymph nodes.\n2. Contraindication to the application of SPT dressing (e.g. allergy).\n3. Pregnancy/lactation or women of childbearing potential who are unable or unwilling to use adequate contraception during RT.\n4. Planned RT course >4 weeks or <3 weeks.\n5. Active connective tissue disorders/collagen vascular disease, specifically dermatomyositis with a CPK level above normal or with an active skin rash in the area that will receive RT, systemic lupus erythematosis, or scleroderma.\n6. Medical, psychiatric or other condition that would prevent the patient from receiving the protocol therapy or providing informed consent.\n7. Known sensitivity or allergy to silver or nylon.",
        "miscellaneous_criteria": ""
    },
    "inclusion_lines": [
        {
            "line": "Must have minimum age of 18 Years",
            "criterions": [
                {
                    "exact_snippets": "minimum age of 18 Years",
                    "criterion": "age",
                    "requirements": [
                        {
                            "requirement_type": "minimum",
                            "expected_value": {
                                "operator": ">=",
                                "value": 18,
                                "unit": "years"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "5. Agreeable that any normal or physician recommended skin care regimen is to be used 1 hour prior to use of SPT dressing.",
            "criterions": [
                {
                    "exact_snippets": "any normal or physician recommended skin care regimen is to be used 1 hour prior to use of SPT dressing",
                    "criterion": "skin care regimen",
                    "requirements": [
                        {
                            "requirement_type": "type",
                            "expected_value": [
                                "normal",
                                "physician recommended"
                            ]
                        },
                        {
                            "requirement_type": "timing",
                            "expected_value": {
                                "operator": "=",
                                "value": 1,
                                "unit": "hour prior to use of SPT dressing"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "Healthy volunteers allowed",
            "criterions": [
                {
                    "exact_snippets": "Healthy volunteers allowed",
                    "criterion": "healthy volunteer status",
                    "requirements": [
                        {
                            "requirement_type": "eligibility",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "6. Agreeable to completion of assessments and skin checks and in person follow up at about 1 month following completion of RT.",
            "criterions": [
                {
                    "exact_snippets": "Agreeable to completion of assessments",
                    "criterion": "willingness to complete assessments",
                    "requirements": [
                        {
                            "requirement_type": "willingness",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "Agreeable to ... skin checks",
                    "criterion": "willingness to undergo skin checks",
                    "requirements": [
                        {
                            "requirement_type": "willingness",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "Agreeable to ... in person follow up at about 1 month following completion of RT",
                    "criterion": "willingness to attend in-person follow-up at 1 month post-RT",
                    "requirements": [
                        {
                            "requirement_type": "willingness",
                            "expected_value": true
                        },
                        {
                            "requirement_type": "timing",
                            "expected_value": {
                                "operator": "=",
                                "value": 1,
                                "unit": "month post-RT"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "2. Male or female patients with breast cancer or breast carcinoma in situ who are recommended to receive adjuvant radiotherapy to the breast +/- regional lymph nodes or are planned to receive adjuvant radiotherapy to the chest wall and regional lymph nodes over 3 to 4 weeks.",
            "criterions": [
                {
                    "exact_snippets": "Male or female patients",
                    "criterion": "sex",
                    "requirements": [
                        {
                            "requirement_type": "allowed_values",
                            "expected_value": [
                                "male",
                                "female"
                            ]
                        }
                    ]
                },
                {
                    "exact_snippets": "breast cancer or breast carcinoma in situ",
                    "criterion": "diagnosis",
                    "requirements": [
                        {
                            "requirement_type": "allowed_values",
                            "expected_value": [
                                "breast cancer",
                                "breast carcinoma in situ"
                            ]
                        }
                    ]
                },
                {
                    "exact_snippets": "recommended to receive adjuvant radiotherapy to the breast +/- regional lymph nodes or are planned to receive adjuvant radiotherapy to the chest wall and regional lymph nodes",
                    "criterion": "adjuvant radiotherapy plan",
                    "requirements": [
                        {
                            "requirement_type": "treatment_recommendation_or_plan",
                            "expected_value": "adjuvant radiotherapy to the breast +/- regional lymph nodes OR adjuvant radiotherapy to the chest wall and regional lymph nodes"
                        }
                    ]
                },
                {
                    "exact_snippets": "over 3 to 4 weeks",
                    "criterion": "adjuvant radiotherapy duration",
                    "requirements": [
                        {
                            "requirement_type": "duration",
                            "expected_value": {
                                "comparisons": [
                                    {
                                        "operator": ">=",
                                        "value": 3,
                                        "unit": "weeks"
                                    },
                                    {
                                        "operator": "<=",
                                        "value": 4,
                                        "unit": "weeks"
                                    }
                                ]
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "7. Must have the ability to understand and the willingness to sign a written informed consent document.",
            "criterions": [
                {
                    "exact_snippets": "Must have the ability to understand",
                    "criterion": "ability to understand",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "willingness to sign a written informed consent document",
                    "criterion": "willingness to sign informed consent",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "1. ECOG ≤ 2",
            "criterions": [
                {
                    "exact_snippets": "ECOG ≤ 2",
                    "criterion": "ECOG performance status",
                    "requirements": [
                        {
                            "requirement_type": "score",
                            "expected_value": {
                                "operator": "<=",
                                "value": 2,
                                "unit": "N/A"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "4. Agreeable to use of SPT dressing as directed (changing once weekly during RT and the additional 2 weeks following completion of RT).",
            "criterions": [
                {
                    "exact_snippets": "Agreeable to use of SPT dressing as directed (changing once weekly during RT and the additional 2 weeks following completion of RT)",
                    "criterion": "use of SPT dressing",
                    "requirements": [
                        {
                            "requirement_type": "willingness/consent",
                            "expected_value": true
                        },
                        {
                            "requirement_type": "adherence to dressing change schedule",
                            "expected_value": "once weekly during RT and the additional 2 weeks following completion of RT"
                        }
                    ]
                }
            ]
        },
        {
            "line": "3. Patients who will receive all of their RT at Magee Women's Hospital.",
            "criterions": [
                {
                    "exact_snippets": "Patients who will receive all of their RT at Magee Women's Hospital.",
                    "criterion": "location of radiotherapy (RT) administration",
                    "requirements": [
                        {
                            "requirement_type": "location",
                            "expected_value": "Magee Women's Hospital"
                        },
                        {
                            "requirement_type": "completeness",
                            "expected_value": "all RT"
                        }
                    ]
                }
            ]
        }
    ],
    "exclusion_lines": [
        {
            "line": "7. Known sensitivity or allergy to silver or nylon.",
            "criterions": [
                {
                    "exact_snippets": "Known sensitivity or allergy to silver",
                    "criterion": "sensitivity or allergy to silver",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "Known sensitivity or allergy to ... nylon",
                    "criterion": "sensitivity or allergy to nylon",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "2. Contraindication to the application of SPT dressing (e.g. allergy).",
            "criterions": [
                {
                    "exact_snippets": "Contraindication to the application of SPT dressing (e.g. allergy)",
                    "criterion": "contraindication to SPT dressing",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "6. Medical, psychiatric or other condition that would prevent the patient from receiving the protocol therapy or providing informed consent.",
            "criterions": [
                {
                    "exact_snippets": "Medical, psychiatric or other condition that would prevent the patient from receiving the protocol therapy",
                    "criterion": "medical, psychiatric, or other condition",
                    "requirements": [
                        {
                            "requirement_type": "impact on protocol therapy",
                            "expected_value": "would prevent the patient from receiving the protocol therapy"
                        }
                    ]
                },
                {
                    "exact_snippets": "Medical, psychiatric or other condition that would prevent the patient from ... providing informed consent",
                    "criterion": "medical, psychiatric, or other condition",
                    "requirements": [
                        {
                            "requirement_type": "impact on informed consent",
                            "expected_value": "would prevent the patient from providing informed consent"
                        }
                    ]
                }
            ]
        },
        {
            "line": "1. Prior RT to the breast +/- regional lymph nodes or prior RT to the chest wall and regional lymph nodes.",
            "criterions": [
                {
                    "exact_snippets": "Prior RT to the breast +/- regional lymph nodes",
                    "criterion": "prior radiotherapy to the breast and/or regional lymph nodes",
                    "requirements": [
                        {
                            "requirement_type": "history",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "prior RT to the chest wall and regional lymph nodes",
                    "criterion": "prior radiotherapy to the chest wall and regional lymph nodes",
                    "requirements": [
                        {
                            "requirement_type": "history",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "3. Pregnancy/lactation or women of childbearing potential who are unable or unwilling to use adequate contraception during RT.",
            "criterions": [
                {
                    "exact_snippets": "Pregnancy/lactation",
                    "criterion": "pregnancy",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": false
                        }
                    ]
                },
                {
                    "exact_snippets": "Pregnancy/lactation",
                    "criterion": "lactation",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": false
                        }
                    ]
                },
                {
                    "exact_snippets": "women of childbearing potential who are unable or unwilling to use adequate contraception during RT",
                    "criterion": "contraception use during RT in women of childbearing potential",
                    "requirements": [
                        {
                            "requirement_type": "ability to use contraception",
                            "expected_value": true
                        },
                        {
                            "requirement_type": "willingness to use contraception",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "4. Planned RT course >4 weeks or <3 weeks.",
            "criterions": [
                {
                    "exact_snippets": "Planned RT course >4 weeks or <3 weeks.",
                    "criterion": "planned radiotherapy (RT) course duration",
                    "requirements": [
                        {
                            "requirement_type": "duration",
                            "expected_value": {
                                "comparisons": [
                                    {
                                        "operator": ">",
                                        "value": 4,
                                        "unit": "weeks"
                                    },
                                    {
                                        "operator": "<",
                                        "value": 3,
                                        "unit": "weeks"
                                    }
                                ]
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "5. Active connective tissue disorders/collagen vascular disease, specifically dermatomyositis with a CPK level above normal or with an active skin rash in the area that will receive RT, systemic lupus erythematosis, or scleroderma.",
            "criterions": [
                {
                    "exact_snippets": "Active connective tissue disorders/collagen vascular disease",
                    "criterion": "connective tissue disorders/collagen vascular disease",
                    "requirements": [
                        {
                            "requirement_type": "activity",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "dermatomyositis with a CPK level above normal",
                    "criterion": "dermatomyositis",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        },
                        {
                            "requirement_type": "CPK level",
                            "expected_value": {
                                "operator": ">",
                                "value": 0,
                                "unit": "above normal"
                            }
                        }
                    ]
                },
                {
                    "exact_snippets": "dermatomyositis ... with an active skin rash in the area that will receive RT",
                    "criterion": "dermatomyositis",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        },
                        {
                            "requirement_type": "active skin rash in the area that will receive RT",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "systemic lupus erythematosis",
                    "criterion": "systemic lupus erythematosis",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "scleroderma",
                    "criterion": "scleroderma",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    ]
                }
            ]
        }
    ],
    "miscellaneous_lines": [],
    "failed_inclusion": [],
    "failed_exclusion": [],
    "failed_miscellaneous": []
}